Multifaceted cancer alleviation by cowpea mosaic virus in a bioprinted ovarian cancer peritoneal spheroid model

Biomaterials. 2024 Dec:311:122663. doi: 10.1016/j.biomaterials.2024.122663. Epub 2024 Jun 10.

Abstract

Ovarian cancer (OvCa) is a leading cause of mortality among gynecological malignancies and usually manifests as intraperitoneal spheroids that generate metastases, ascites, and an immunosuppressive tumor microenvironment. In this study, we explore the immunomodulatory properties of cowpea mosaic virus (CPMV) as an adjuvant immunotherapeutic agent using an in vitro model of OvCa peritoneal spheroids. Previous findings highlighted the potent efficacy of intratumoral CPMV against OvCa in mouse tumor models. Leveraging the precision control over material deposition and cell patterning afforded by digital-light-processing (DLP) based bioprinting, we constructed OvCa-macrophage spheroids to mimic peritoneal spheroids using gelatin methacrylate (GelMA), a collagen-derived photopolymerizable biomaterial to mimic the extracellular matrix. Following CPMV treatment, bioprinted spheroids exhibited inhibited OvCa progression mediated by macrophage activation. Our analysis indicates that CPMV regulates and activates macrophage to both induce OvCa cell killing and restore normal cell-cell junctions. This study deepened our understanding of the mechanism of CPMV intratumoral immunotherapy in the setting of OvCa. This study also highlights the potential of studying immunotherapies using high throughput tissue models via DLP bioprinting.

Keywords: 3D bioprinting; Cancer immunotherapy; Cowpea mosaic virus; In vitro models; Ovarian cancer.

MeSH terms

  • Animals
  • Bioprinting* / methods
  • Cell Line, Tumor
  • Comovirus*
  • Female
  • Humans
  • Immunotherapy / methods
  • Macrophages / virology
  • Mice
  • Ovarian Neoplasms* / pathology
  • Ovarian Neoplasms* / virology
  • Spheroids, Cellular* / pathology
  • Spheroids, Cellular* / virology